# Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea

> **NCT00310323** · NA · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 69 (actual)

## Conditions studied

- Sleep Apnea

## Interventions

- **DRUG:** Dextromethorphan
- **DRUG:** Caffeine

## Key facts

- **NCT ID:** NCT00310323
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2009-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00310323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00310323, "Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00310323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*